Lucy Scientific Discovery Inc. LSDI NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

21/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Lucy Scientific Discovery Inc. (LSDI) reported total assets of $8.78M and total liabilities of $4.1M for fiscal year 2023, resulting in total equity of $4.68M.

The company held $1.67M in cash and short-term investments. Total debt stood at $1.79M, with net debt of $114.93K. The Debt-to-Equity (D/E) ratio was 0.38 (conservative).

Current ratio is 1.41, suggesting adequate short-term liquidity. Interest coverage is -3x (weak).

Criteria supported by this page:

HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
MOAT (32/100) — Total assets $8.78M and equity $4.68M support the company's competitive scale

Overall SharesGrow Score: 20/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

21/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

32/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Lucy Scientific Discovery Inc. Balance Sheet History

Metric	FY2023	FY2022	FY2021	FY2020
Total Assets	$8.78M	$4.63M	$5.55M	$119.43K
Total Liabilities	$4.1M	$9.41M	$11.91M	$4.46M
Total Debt	$1.79M	$4.82M	$2.19M	$1.27M
Cash & Investments	$1.67M	$53.38K	$246.03K	$50.02K
Total Stockholders Equity	$4.68M	$-4.78M	$-6.36M	$-4.34M